IRVINE, Calif., Feb. 15 /PRNewswire/ -- DataLabs, an innovative developer of Internet-based applications for clinical development, announced today it has been selected as the exclusive provider of electronic clinical data management technology for Promedica International, a California Corporation, which is a privately held contract research organization (CRO).
Promedica selected the DataLabsXC suite of software for study design, data capture and data management from among a field of 18 companies that responded to Promedica's request for information. According to Ellen Palo, president of Promedica International, DataLabs won the business because of three key factors:
-- DataLabs understands the CRO business and supports Promedica's needs
as a partner, not a competitor.
-- DataLabs provided compelling, credible evidence of its software
performance and ability to accelerate clinical trials.
-- DataLabs software builds on Promedica's current Microsoft-based
technology hardware, software and resource training investment.
"We selected DataLabs because they are positioned as a software company and do not compete with CROs or our services, said Palo. "DataLabs provides us with a model to increase our service revenue because technology transfer is DataLabs' number one objective. Promedica can absorb DataLabs' technology and get on with our business."
Unlike traditional application service provider (ASP) models, DataLabsXC offers CROs the flexibility to adapt the software to unique specifications and conduct studies in a cost-effective manner. Based on Microsoft platform technology, XML Web services and the CDISC ODM standard, DataLabsXC easily adapts to each sponsor's established operating procedures and integrates easily with existing technology systems. As a result, CROs enjoy a low total cost of ownership and high return on investment. As a member of the DataLabs CRO Partner Program, Promedica will enjoy a host of benefits and services designed especially for CROs.
"DataLabs is committed to providing tools to Promedica that will greatly enhance the company's business and make the highest impact possible," said Jim Langford, president of DataLabs. "Our relationship with Promedica is a perfect example of how the DataLabs CRO Partner Program can add value for CROs of all types and sizes."
According to Palo, DataLabs technology offers Promedica the ability to optimize its business by increasing efficiencies and giving Promedica the flexibility to meet clients' varied needs. "The important customization features of DataLabsXC technology foster an opportunity to enhance service to our clients based on their needs, not the needs of the software," Palo said. "It gives us the option of technology scalability. What benefits our clients benefits Promedica."
The DataLabs CRO Partner Program makes accelerating clinical trials easy and affordable with a suite of software, services and benefits designed specifically for the unique needs of CROs. The program includes the DataLabsXC CRO Edition software suite for clinical study design, electronic data capture and data management, which can be privately labeled to the CRO partner and is configurable to meet the various processes of CROs' pharmaceutical clients. The program also features flexible pricing options that provide partners with a path to increased revenues, a CRO service program designed to meet the special needs of organizations using software to provide outsourced services, and the opportunity for charter members to join the DataLabs CRO Advisory Board. For more information, please visit http://www.datalabs.com/CRO.html.
About Promedica International
Promedica International is a contract research organization that provides clinical and regulatory expertise to the medical device, pharmaceutical and biotechnology industries. Nearly two decades of experience shapes our understanding of the many clinical and regulatory challenges facing healthcare providers and the healthcare industry today. Our professional staff and consultants have insight and expertise acquired across a broad range of medical specialties and therapeutic areas. Our ISO-based work processes provide each project uninterrupted consistency, accuracy and attention to detail. These organizational assets -- people and processes -- are the driving forces behind our goal to provide a level of performance that meets professional standards of quality and reliability for every client, regardless of size or location. For more information, please visit http://www.promedica-intlcro.com/.
DataLabs is an innovative developer of Internet-based applications for clinical development that helps the biopharmaceutical industry accelerate clinical trials with proven software for study design, data capture and data management. Based on Microsoft platform technology, XML Web services and CDISC ODM standards, the DataLabsXC product suite adapts to established operating procedures and integrates easily with existing technology systems. As a result, DataLabsXC customers enjoy a low total cost of ownership and high return on investment. Major pharmaceutical companies, government entities, healthcare organizations and contract research organizations are currently realizing time and cost savings using DataLabsXC. DataLabs is based in Irvine, Calif. with East Coast offices in Pennsylvania. For more information, please visit http://www.datalabs.com/.